FUi002-A

Registration Summary:

A P E C

D6#5

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	FUi002-A
Cite as:	FUi002-A (RRID:CVCL_VM11)
Alternative name(s)	D6#5
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	11th May 2018
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Fukuoka University (FU)
External Databases
Cellosaurus	CVCL_VM11
Wikidata	Q93557469
General Information
Publications	Tanaka Y et al. Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene. Stem cell research. 2018 Aug;31:11-15. Wang AYL et al. Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications. Cell transplantation. 2019 Dec;28(1_suppl):112S-131S. Page S et al. Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cells. Biochimica et biophysica acta. Molecular basis of disease. 2020 Apr 1;1866(4):165358. Hirose S et al. Application of induced pluripotent stem cells in epilepsy. Molecular and cellular neurosciences. 2020 Oct;108:103535. Zayat V et al. Concise Review: Stem Cell Models of SCN1A-Related Encephalopathies-Current Perspective and Future Therapies. Cells. 2022 Oct 4;11(19). Javaid MS et al. Human In Vitro Models of Epilepsy Using Embryonic and Induced Pluripotent Stem Cells. Cells. 2022 Dec 7;11(24). Guerrini R et al. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiological reviews. 2023 Jan 1;103(1):433-513.

hIPSC Derivation

General